Page last updated: 2024-11-04

rolipram and Bradyarrhythmia

rolipram has been researched along with Bradyarrhythmia in 2 studies

Research Excerpts

ExcerptRelevanceReference
" All three PDE4 inhibitors were administered at 1, 10, or 100 microg/kg (iv) 15 min prior to the induction of bradycardia by an iv injection of 2-methyl-5-HT (von Bezold-Jarisch reflex) or by vagal electrical stimulation."3.70Selective potentiating effect of RS14203 on a serotoninergic pathway in anesthetized rats. ( Chan, CC; Robichaud, A; Rodger, IW; Savoie, C, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galindo-Tovar, A1
Vargas, ML1
Kaumann, AJ1
Savoie, C1
Chan, CC1
Rodger, IW1
Robichaud, A1

Other Studies

2 other studies available for rolipram and Bradyarrhythmia

ArticleYear
Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Naunyn-Schmiedeberg's archives of pharmacology, 2009, Volume: 379, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Arrhythmia, Sinus; Atrial Fu

2009
Selective potentiating effect of RS14203 on a serotoninergic pathway in anesthetized rats.
    Canadian journal of physiology and pharmacology, 2000, Volume: 78, Issue:9

    Topics: Afferent Pathways; Animals; Bradycardia; Efferent Pathways; Electric Stimulation; Heart Rate; Male;

2000